175 related articles for article (PubMed ID: 18344909)
21. Subcutaneous sacrococcygeal ("myxopapillary") ependymal rests.
Pulitzer DR; Martin PC; Collins PC; Ralph DR
Am J Surg Pathol; 1988 Sep; 12(9):672-7. PubMed ID: 2458048
[TBL] [Abstract][Full Text] [Related]
22. Ependymomas in adults.
Gilbert MR; Ruda R; Soffietti R
Curr Neurol Neurosci Rep; 2010 May; 10(3):240-7. PubMed ID: 20425040
[TBL] [Abstract][Full Text] [Related]
23. Analysis of squash smear cytology of ependymomas.
Manasa PL; Uppin MS; Sundaram C
Acta Cytol; 2012; 56(2):183-8. PubMed ID: 22378082
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China.
Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z
BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163
[TBL] [Abstract][Full Text] [Related]
25. Strong OLIG2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.
de Castro JVA; Kulikowski LD; Wolff BM; Natalino R; Carraro DM; Torrezan GT; Scapulatempo Neto C; Amancio CT; Canedo FSNA; Feher O; Costa FD
Neuropathology; 2024 Apr; 44(2):167-172. PubMed ID: 37855183
[TBL] [Abstract][Full Text] [Related]
26. Radiologic characteristics of ependymomas: a case-based approach.
Khatami D; Kasper EM; Bhadelia R; Rojas R
J Neurosurg Sci; 2018 Feb; 62(1):38-45. PubMed ID: 28945051
[TBL] [Abstract][Full Text] [Related]
27. Chordoid glioma of the third ventricle: a report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature.
Pasquier B; Péoc'h M; Morrison AL; Gay E; Pasquier D; Grand S; Sindou M; Kopp N
Am J Surg Pathol; 2002 Oct; 26(10):1330-42. PubMed ID: 12360048
[TBL] [Abstract][Full Text] [Related]
28. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
30. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
31. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
32. Canine Ependymoma: Diagnostic Criteria and Common Pitfalls.
Miller AD; Koehler JW; Donovan TA; Stewart JE; Porter BF; Rissi DR; Priestnall SL; Schulman FY
Vet Pathol; 2019 Nov; 56(6):860-867. PubMed ID: 31266414
[TBL] [Abstract][Full Text] [Related]
33. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
Pajtler KW; Witt H; Sill M; Jones DT; Hovestadt V; Kratochwil F; Wani K; Tatevossian R; Punchihewa C; Johann P; Reimand J; Warnatz HJ; Ryzhova M; Mack S; Ramaswamy V; Capper D; Schweizer L; Sieber L; Wittmann A; Huang Z; van Sluis P; Volckmann R; Koster J; Versteeg R; Fults D; Toledano H; Avigad S; Hoffman LM; Donson AM; Foreman N; Hewer E; Zitterbart K; Gilbert M; Armstrong TS; Gupta N; Allen JC; Karajannis MA; Zagzag D; Hasselblatt M; Kulozik AE; Witt O; Collins VP; von Hoff K; Rutkowski S; Pietsch T; Bader G; Yaspo ML; von Deimling A; Lichter P; Taylor MD; Gilbertson R; Ellison DW; Aldape K; Korshunov A; Kool M; Pfister SM
Cancer Cell; 2015 May; 27(5):728-43. PubMed ID: 25965575
[TBL] [Abstract][Full Text] [Related]
34. Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.
Hongo H; Takai K; Komori T; Taniguchi M
J Neurosurg Spine; 2018 Oct; 30(1):133-139. PubMed ID: 30485241
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors.
Ebrahimi A; Schittenhelm J; Honegger J; Schluesener H
J Neurosurg; 2013 Dec; 119(6):1424-31. PubMed ID: 24116725
[TBL] [Abstract][Full Text] [Related]
36. Updates in Molecular Pathology of Central Nervous System Gliomas in Adults.
Punsoni M; Donahue JE; Elinzano HD; Kinsella T
R I Med J (2013); 2015 Nov; 98(11):17-9. PubMed ID: 26517249
[TBL] [Abstract][Full Text] [Related]
37. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
38. Molecular alterations in ependymomas.
Biernat W; Zawrocki A
Folia Neuropathol; 2007; 45(4):155-63. PubMed ID: 18176888
[TBL] [Abstract][Full Text] [Related]
39. Cytologic findings in malignant ependymoma: a case report.
Azarpira N; Rakei M; Mokhtari M
Acta Cytol; 2010; 54(5 Suppl):1023-6. PubMed ID: 21053591
[TBL] [Abstract][Full Text] [Related]
40. Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression.
Mannoji H; Becker LE
Cancer; 1988 Apr; 61(7):1377-85. PubMed ID: 2449946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
